Drug Approvals
BioMarin Pharmaceutical Is Ready to Start a Fresh Advance
Here's where aggressive traders could go long BMRN.
I Don't Love Biogen, But Here's How to Trade It
I'm not saying get married to the stock, I'm saying that the idea could be a trade based on two possible catalysts.
Buying Moderna Now Could Be Akin to Trying to Catch a Falling Knife
Here's what traders can do.
Pfizer Is a Low-Beat, Dividend Stock: Here's What Patient Investors Can Do
Pfizer attributed the quarter's sales of Comirnaty, the firm's Covid-19 Messenger RNA vaccine, for the size of the top and bottom line beats.
2 Promising Small Biotechs in a Year That Has Been Tough on Most Little Guys
There are reasons to believe the shares of Dynavax Technologies and Eyenovia Inc. could do well in the months ahead.
What a Week, China's Troubles, Hypersonic Weapons, Earnings, FDA Drug Approvals
The lack of urgency at the FDA, as it is in the defense space, is alarming.
Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up
A recent trio of acquisition deals indicates the doldrums in the sector may be over.
Merck Continues to Reward Buyers
Investors are using the available weakness to buy the stock.
A Day Never to Forget, Red-Hot Debt Market, Moderna Marches On, Biden Thumbs Up
Plus, Zscaler largely delivers for its owners with its latest results.